CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
Roma, RM, Italy and 66 other locations
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas....
Phase 1, Phase 2
Rome, Italy and 59 other locations
Prospective, multicenter, open label, phase III randomized clinical trial in previously untreated Follicular Lymphoma in early stage. Patien...
Phase 3
Roma, Italy and 47 other locations
and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refractory classical Hodgkin lymphoma...
Phase 1, Phase 2
Roma, Italy and 75 other locations
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...
Phase 2
Roma, Italy and 93 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Roma, Lazio, Italy and 215 other locations
to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...
Phase 2
Rome, Lazio, Italy and 67 other locations
New Zealand, in elderly patients with untreated diffuse large B-cell lymphoma. Elderly is defined as either ≥80 years of age, or ≥75 years a...
Phase 3
Roma, Italy and 69 other locations
The purpose of this study is to define the objective response rates (ORR) of Lorlatinib in subjects with ALK+ lymphomas resistant or refract...
Phase 2
Roma, Italy and 1 other location
A multicenter, open-label Phase 2b study of selinexor (KPT-330) in participants with relapsed/refractory (R/R) diffuse large B-cell lymphoma...
Phase 2
Rome, Italy and 175 other locations
Clinical trials
Research sites
Resources
Legal